Pacific Sage Partners, LLC Infinity Pharmaceuticals, Inc. Transaction History

Pacific Sage Partners, LLC

  • $420 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023
BUY
$0.16 - $0.74 $400 - $1,850
2,500 Added 14.29%
20,000 $3.2 Million
Q4 2022

Jan 31, 2023
BUY
$0.46 - $1.21 $8,050 - $21,175
17,500 New
17,500 $9.71 Million

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Pacific Sage Partners, LLC Portfolio

Follow Pacific Sage Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Sage Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Sage Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email